These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22753758)

  • 1. New molecularly targeted therapies for glioblastoma multiforme.
    Polivka J; Polivka J; Rohan V; Topolcan O; Ferda J
    Anticancer Res; 2012 Jul; 32(7):2935-46. PubMed ID: 22753758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New therapeutic options in therapy of glioblastoma multiforme].
    Lakomý R; Burkon P; Burkonová D; Jancálek R
    Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized targeted therapy for glioblastoma: fact or fiction?
    Weller M; Stupp R; Hegi M; Wick W
    Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme.
    Okonogi N; Shirai K; Oike T; Murata K; Noda SE; Suzuki Y; Nakano T
    Anticancer Res; 2015 Mar; 35(3):1229-35. PubMed ID: 25750269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.
    Quant EC; Wen PY
    Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in therapy for glioblastoma.
    Clarke J; Butowski N; Chang S
    Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer therapies for glioblastoma multiforme.
    Sathornsumetee S; Rich JN
    Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
    Reardon DA; Wen PY
    Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between response to primary treatments and MGMT status in glioblastoma.
    Franceschi E; Tosoni A; Pozzati E; Brandes AA
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1781-6. PubMed ID: 18983238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
    Bambury RM; Morris PG
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
    Jagannathan J; Prevedello DM; Dumont AS; Laws ER
    Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme: a review of where we have been and where we are going.
    Adamson C; Kanu OO; Mehta AI; Di C; Lin N; Mattox AK; Bigner DD
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1061-83. PubMed ID: 19555299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of glioblastoma in the elderly.
    Sahebjam S; McNamara M; Mason WP
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):379-86. PubMed ID: 22895239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis: a novel therapeutic target for glioblastoma.
    Jiang YG; Peng Y; Koussougbo KS
    Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards tailored therapy of glioblastoma multiforme.
    Rekers NH; Sminia P; Peters GJ
    J Chemother; 2011 Aug; 23(4):187-99. PubMed ID: 21803695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.